Once hailed as the global center for GlaxoSmithKline PLC in the central nervous systems therapeutic area, the research hub in China is now being wound up.
Located in Shanghai's sleek Zhangjiang Hitech zone in Pudong New District, the center was opened in 2007 with much fanfare and an ambitious goal to tackle neurodegeneration disorders, including